The 5th-generation real-loss insurance, which financial authorities had planned to launch within this year, remains unannounced. To introduce a new real-loss insurance product, insurance companies ...

Eli Lilly LLY0.50%increase; green up pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

Eli Lilly (LLY) announced on Thursday that a late-stage trial for its next-generation weight loss candidate, retatrutide, met all primary and key secondary endpoints in obese or overweight adults with ...

Retatrutide shows highest weight loss to date in trial Lilly says trial departures due to perceived excessive weight loss Retatrutide shows elevated skin-related side effects Dec 11 (Reuters) - Eli ...